Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

The First Affiliated Hospital With Nanjing Medical University

Clinical trials sponsored by The First Affiliated Hospital With Nanjing Medical University, explained in plain language.

Trials to join now! 29 Not yet recruiting 21 Not yet finished but already full! 3 Completed 6 Terminated 1

New Two-Pronged cell therapy tested for tough cancers

Disease control Terminated

This early-stage study tested a new type of cell therapy called LUCAR-G39P in adults with B-cell non-Hodgkin lymphoma that has come back or not responded to other treatments. The therapy uses the patient's own modified immune cells to target two markers on the cancer cells. The m…

Phase: PHASE1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control

Last updated Mar 19, 2026 14:56 UTC